Akanda Corp. · NASDAQ:AKAN

Akanda — Investor Presentation (November 2022)

13 slides from Akanda's investor presentation, November 2022

  1. Slide 1: Europe's Premium Cannabis Cultivator, November 2022

    E U R O P E ’ S P R E M I U M C A N N A B I S C U L T I V A T O R N O V E M B E R 2 0 2 2

  2. Slide 2: Disclaimer: Forward-Looking Statements

    DISCLAIMER FORWARD-LOOKING STATEMENTS Various statements contained in this presentation, including those that express a belief, expectation or intention, as well as those that are not statements of historical fact, are forward-looking statements. These forward-looking statements may include projecti

  3. Slide 3: Company Profile & Investment Highlights

    Company Profile & Investment Highlights PREMIUM INDOOR CULTIVATION COMPANY PROFILE • The only commercial scale premium indoor EU GMP certified and licensed grow in Portugal • 2,000kg+ annual production, generating revenue with large German offtake agreement Founded: 2021 • Clean testing non-irradiat

  4. Slide 4: Akanda's Experienced European Leadership Team

    Akanda’s Experienced European Leadership Team TEJ VIRK CEO & Director Proven leader with over 15 years of executive-level STEVE GEORGE JOSH SQUIRES-QUINN experience in the capital markets and cannabis Commercial Director Business Development industry, including previously serving as Managing Directo

  5. Slide 5: Akanda is Europe's Premium Cannabis Cultivator

    Akanda is Europe’s Premium Cannabis Cultivator World-leading EU GMP-certified cultivation facility in Portugal distributing premium medical cannabis to fast-growing markets in Europe. PREMIUM QUALITY ADVANCED MARKET CULTIVATION PACKAGING ACCESS Committed to highest quality standards under EU EU GMP

  6. Slide 6: Portugal is Europe's Heart of Production for Cannabis

    Portugal is Europe’s Heart of Production for Cannabis Since legalizing medical cannabis in 2018, Portugal has become a global hub for medical cannabis production Low production costs Solid reputation with extensive within Europe pharma capabilities Close to large markets like Barriers to entry are h

  7. Slide 7: German Cannabis Market In Focus

    German Cannabis Market In Focus Akanda’s premium indoor high THC flower is in demand by patients and now shipping to Germany GERMANY LEADING THE WAY $2.2b Population 83.2 MILLION In November 2021, the incoming Potential growth to by 20263 governing coalition reaches Total Addressable Market3 agreeme

  8. Slide 8: EU GMP Premium Indoor Cultivation

    EU GMP Premium Indoor Cultivation AN AKANDA COMPANY SINTRA FACILITY Purpose-built design, Self contained modular all unnecessary equipment grow rooms, allowing for sitting outside of the rooms better environmental Ø 2,000kg to reduce contamination risk control and the per year production of high- qu

  9. Slide 9: Genetics & Brand Partnership

    Genetics & Brand Partnership Akanda is the exclusive cultivation and retail partner for Cookies in Portugal, bringing California style cannabis to Europe Berner, Co-Founder and CEO of Cookies: "The fact Portugal decriminalized drugs back in the early 2000’s and people in the U.S. are still being loc

  10. Slide 10: Current Expansion Opportunities in Portugal

    Current Expansion Opportunities in Portugal AN AKANDA COMPANY SINTRA, PORTUGAL ALJUSTREL, PORTUGAL INDOOR CULTIVATION & PACKAGING OUTDOOR & GREENHOUSE CULTIVATION 10 20,000 7 million 100 28,000 Tonnes* annual square feet square feet tonnes annual square feet of production capacity indoor facility (1

  11. Slide 11: Akanda is Supplying the UK Medical Cannabis Market

    Akanda is Supplying the UK Medical Cannabis Market Product Journey + 1. Canmart imports 2. Canmart manages medical cannabis to inventory with Phlo and supply UK Wholesalers Leva for next day delivery and Pharmacies to patients Repeat Rx Patient Journey 1. Patient books 2. Virtual consultation with 3

  12. Slide 12: European Cannabis is Attractive to Smart Money Investors

    European Cannabis is Attractive to Smart Money Investors ~$200m in strategic investments have been made into early stage European cannabis companies recently APRIL OCTOBER FEBRUARY SEPTEMBER SEPTEMBER 2021 2021 2022 2022 2022 Curaleaf acquires Bloomwell Group Casa Verde Leads Curaleaf agreement to B

  13. Slide 13: Thank You

    THANK YOU GET IN TOUCH WITH US TEJ VIRK CEO & DIRECTOR TEJ@AKANDACORP.COM

Akanda — Investor Presentation (November 2022) on 6ix